PortfoliosLab logoPortfoliosLab logo
CVS vs. INGR
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CVS vs. INGR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CVS Health Corporation (CVS) and Ingredion Incorporated (INGR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CVS achieves a 30.67% return, which is significantly higher than INGR's -6.49% return. Over the past 10 years, CVS has outperformed INGR with an annualized return of 3.70%, while INGR has yielded a comparatively lower 0.79% annualized return.


CVS

1D
1.47%
1M
3.92%
YTD
30.67%
6M
30.57%
1Y
59.29%
3Y*
16.60%
5Y*
7.08%
10Y*
3.70%

INGR

1D
0.68%
1M
-4.15%
YTD
-6.49%
6M
-8.29%
1Y
-25.12%
3Y*
0.77%
5Y*
4.31%
10Y*
0.79%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CVS vs. INGR - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CVS
CVS Health Corporation
30.67%84.35%-40.77%-12.53%-7.63%54.87%-5.14%17.26%-7.04%-5.75%
INGR
Ingredion Incorporated
-6.49%-17.86%29.22%14.08%4.47%26.35%-12.55%4.70%-33.10%13.87%

Correlation

The correlation between CVS and INGR is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.14

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.24

Correlation (10Y)
Calculated over the trailing 10-year period

0.28

Correlation (All Time)
Calculated using the full available price history since Dec 11, 1997

0.24

The correlation between CVS and INGR shifts across timeframes, from 0.14 (1 year) to 0.28 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

EPS

CVS:

$2.30

INGR:

$13.96

PE Ratio

CVS:

44.29

INGR:

7.28

PS Ratio

CVS:

0.32

INGR:

0.92

Total Revenue (TTM)

CVS:

$407.91B

INGR:

$5.41B

Gross Profit (TTM)

CVS:

$56.59B

INGR:

$1.36B

EBITDA (TTM)

CVS:

$9.99B

INGR:

$902.00M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CVS vs. INGR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CVS
CVS Risk / Return Rank: 8686
Overall Rank
CVS Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
CVS Sortino Ratio Rank: 8282
Sortino Ratio Rank
CVS Omega Ratio Rank: 8787
Omega Ratio Rank
CVS Calmar Ratio Rank: 8888
Calmar Ratio Rank
CVS Martin Ratio Rank: 8787
Martin Ratio Rank

INGR
INGR Risk / Return Rank: 33
Overall Rank
INGR Sharpe Ratio Rank: 00
Sharpe Ratio Rank
INGR Sortino Ratio Rank: 22
Sortino Ratio Rank
INGR Omega Ratio Rank: 33
Omega Ratio Rank
INGR Calmar Ratio Rank: 44
Calmar Ratio Rank
INGR Martin Ratio Rank: 55
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CVS vs. INGR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for CVS Health Corporation (CVS) and Ingredion Incorporated (INGR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CVSINGRDifference
Sharpe ratioReturn per unit of total volatility

+3.44

Sortino ratioReturn per unit of downside risk

+4.40

Omega ratioGain probability vs. loss probability

1.35

0.75

+0.60

Calmar ratioReturn relative to maximum drawdown

3.62

-0.95

+4.57

Martin ratioReturn relative to average drawdown

9.33

-1.58

+10.91

CVS vs. INGR - Sharpe Ratio Comparison

The current CVS Sharpe Ratio is 1.92, which is higher than the INGR Sharpe Ratio of -1.52. The chart below compares the historical Sharpe Ratios of CVS and INGR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CVS vs. INGR - Drawdown Comparison

The maximum CVS drawdown since its inception was -64.07%, roughly equal to the maximum INGR drawdown of -64.20%. Use the drawdown chart below to compare losses from any high point for CVS and INGR.


Loading charts...

Drawdown Indicators


CVSINGRDifference

Max Drawdown

Largest peak-to-trough decline

-64.07%

-64.20%

+0.13%

Max Drawdown (1Y)

Largest decline over 1 year

-16.44%

-26.58%

+10.14%

Max Drawdown (3Y)

Largest decline over 3 years

-43.98%

-33.21%

-10.77%

Max Drawdown (5Y)

Largest decline over 5 years

-56.79%

-33.21%

-23.58%

Max Drawdown (10Y)

Largest decline over 10 years

-56.79%

-56.14%

-0.65%

Current Drawdown

Current decline from peak

0.00%

-31.78%

+31.78%

Average Drawdown

Average peak-to-trough decline

-19.54%

-18.32%

-1.22%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.38%

16.03%

-9.65%

Volatility

CVS vs. INGR - Volatility Comparison

CVS Health Corporation (CVS) has a higher volatility of 7.50% compared to Ingredion Incorporated (INGR) at 5.82%. This indicates that CVS's price experiences larger fluctuations and is considered to be riskier than INGR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CVSINGRDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.50%

5.82%

+1.68%

Volatility (6M)

Calculated over the trailing 6-month period

25.88%

11.73%

+14.15%

Volatility (1Y)

Calculated over the trailing 1-year period

31.05%

16.64%

+14.41%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

29.98%

21.32%

+8.66%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

29.30%

24.87%

+4.43%

Dividends

CVS vs. INGR - Dividend Comparison

CVS's dividend yield for the trailing twelve months is around 2.61%, less than INGR's 3.21% yield.


PositionTTM20252024202320222021202020192018201720162015
CVS
CVS Health Corporation
2.61%3.35%5.93%3.06%2.36%1.94%2.93%2.69%3.05%2.76%2.15%1.43%
INGR
Ingredion Incorporated
3.21%2.92%1.72%2.75%2.78%2.67%3.23%2.70%2.68%1.57%1.52%1.82%

Financials

CVS vs. INGR - Financials Comparison

This section allows you to compare key financial metrics between CVS Health Corporation and Ingredion Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00B20222023202420252026
100.43B
0
(CVS) Total Revenue
(INGR) Total Revenue
Values in USD except per share items

Frequently Asked Questions


CVS and INGR have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CVS has higher volatility (7.50%) compared to INGR (5.82%). In terms of maximum drawdown, CVS dropped -64.07% vs INGR's -64.20%.

CVS currently has the higher Sharpe Ratio (1.92 vs -1.52), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CVS and INGR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer